Holen Sie sich die Stockscreener-App
2.10
1.41%
-0.03
Schlusskurs vom Vortag:
$2.13
Offen:
$2.18
24-Stunden-Volumen:
27,165
Relative Volume:
0.90
Marktkapitalisierung:
$77.28M
Einnahmen:
$24.38M
Nettoeinkommen (Verlust:
$-53.95M
KGV:
-0.8502
EPS:
-2.47
Netto-Cashflow:
$-23.31M
1W Leistung:
+6.06%
1M Leistung:
+16.02%
6M Leistung:
-34.78%
1J Leistung:
-44.15%
1-Tages-Spanne:
$2.10
$2.24
1-Wochen-Bereich:
$1.76
$2.41
52-Wochen-Spanne:
$1.61
$5.12
Elutia Inc Stock (ELUT) Company Profile
Firmenname
Elutia Inc
Sektor
Branche
Telefon
240-247-1143
Adresse
12510 PROSPERITY DRIVE, SILVER SPRING
Vergleichen Sie ELUT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
2.10 | 81.41M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-02 | Eingeleitet | Cowen | Outperform |
| 2020-11-02 | Eingeleitet | Piper Sandler | Overweight |
| 2020-11-02 | Eingeleitet | Truist | Buy |
Elutia Inc Aktie (ELUT) Neueste Nachrichten
Elutia Inc. Stock Analysis and ForecastExponential return rates - jammulinksnews.com
KAPA Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com
Is TENB a good long term investmentHigh-yield investments - jammulinksnews.com
What makes Elutia Inc. stock price move sharplyRisk Controlled Trading Ideas - Newser
WEAV Stock Analysis and ForecastPowerful growth strategies - jammulinksnews.com
Is Elutia Inc. a good long term investmentExceptional earning trajectories - Autocar Professional
[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Yahoo Finance
What drives Elutia Inc. stock priceDynamic portfolio growth - jammulinksnews.com
What analysts say about Elutia Inc. stockFree Investment Risk Control - jammulinksnews.com
MSPRW Stock Analysis and ForecastExceptional market positioning - Jammu Links News
What analysts say about FatPipe Inc. stockGame-changing returns - jammulinksnews.com
What drives Middlesex Water Company stock priceSkyrocketing profit margins - jammulinksnews.com
Best Growth Stocks Stock Market Research ExpertsSkyrocketing investment returns - jammulinksnews.com
What analysts say about AnaptysBio Inc. stockMassive wealth growth - jammulinksnews.com
Why Elutia Inc. stock attracts strong analyst attentionQuick Profit Idea Stream - Newser
How Elutia Inc. stock performs during market volatilityFree Expert Investment Advice - Newser
Elutia (NASDAQ:ELUT) Trading Down 2.5% – Here’s What Happened - Defense World
Elutia Inc. Announces Promising Study Results for EluPro BioEnvelope in Improving Healing Outcomes for Cardiac Implantable Electronic Devices - Nasdaq
Clinical Study: Revolutionary Antibiotic Technology Shows Superior Results for Heart Implants - Stock Titan
Elutia announces publication of new study on CIED biologic envelope - TipRanks
Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards - GlobeNewswire
Medical Device Network Excellence Awards 2025: Elutia - Medical Device Network
Revenues Working Against Elutia Inc.'s (NASDAQ:ELUT) Share Price - simplywall.st
Elutia Inc. (NASDAQ:ELUT) Shares Purchased by Millennium Management LLC - Defense World
Citadel Advisors LLC Acquires Shares of 22,431 Elutia Inc. (NASDAQ:ELUT) - Defense World
Brokers Issue Forecasts for Elutia FY2026 Earnings - Defense World
Elutia (NASDAQ:ELUT) Shares Down 1% – Time to Sell? - Defense World
Aziyo Biologics Holds Annual Stockholders Meeting - TipRanks
CANTOR FITZGERALD REITERATES ELUTIA STOCK RATING WITH $7 TARGET By Investing.com - Investing.com South Africa
CANTOR FITZGERALD REITERATES ELUTIA STOCK RATING WITH $7 TARGET - Investing.com
Elutia v. Medtronic: Delaware court rules on indemnity and insurance obligations in FiberCel lawsuit - Insurance Business America
ELUT stock touches 52-week low at $1.61 amid market challenges By Investing.com - Investing.com South Africa
ELUT stock touches 52-week low at $1.61 amid market challenges - Investing.com India
Elutia Inc. Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro Testing Method - marketscreener.com
Elutia announces publication of article on measuring antibiotic release - TipRanks
Elutia (ELUT) Innovates with New Antibiotic Release Method | ELUT Stock News - GuruFocus
Revolutionary Drug Testing Method Cuts Medical Device Development Time from 14 Days to Just 30 Hours - Stock Titan
FY2025 EPS Estimates for Elutia Lifted by Cantor Fitzgerald - Defense World
Lake Street Capital Has Lowered Expectations for Elutia (NASDAQ:ELUT) Stock Price - Defense World
Elutia (ELUT) Price Target Reduced by Lake Street | ELUT Stock N - GuruFocus
Finanzdaten der Elutia Inc-Aktie (ELUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):